Management of chronic hepatitis B virus infection in remote-dwelling aboriginals and Torres Strait Islanders: An update for primary healthcare providers

Medical Journal of Australia

Volumn 178, Issue 2, 2003, Pages 82-85

  Fisher, Dale A ^a   Huffam, Sarah E ^a  

^a ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; LIVER ENZYME; NUCLEOSIDE ANALOG; PEGINTERFERON; RECOMBINANT INTERFERON; UNCLASSIFIED DRUG; VIRUS DNA;

ABORIGINE; ALGORITHM; ARTICLE; AUSTRALIA; CANCER RISK; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMMUNITY; COMORBIDITY; CULTURAL FACTOR; DISEASE EXACERBATION; DRUG TOLERABILITY; ENDEMIC DISEASE; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH CARE DELIVERY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; LABORATORY TEST; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; NONHUMAN; PATIENT ATTITUDE; PATIENT CODING; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT REFERRAL; PRIMARY HEALTH CARE; RADIOLOGICAL PROCEDURES; RESOURCE MANAGEMENT; RURAL AREA; SEPSIS; SEROCONVERSION; SEROLOGY; SEX DIFFERENCE; SIDE EFFECT; SURVIVAL; TREATMENT PLANNING; URBAN AREA; VACCINATION;

EID: 0037455280     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05070.x     Document Type: Article

References (25)

1. Condon JR, Warman G, Arnold L, editors. The Health and Welfare of Territorians. Darwin: Epidemiology Branch, Territory Health Services, 2001. http://www.nt.gov.au/health/health_gains/epidemiology/welfare_territorians. pdf (accessed Nov 2002).
2. Australian Bureau of Statistics and Australian Institute of Health and Welfare. The Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples. Canberra: ABS, 2001. (Catalogue No. 4704.0.) Available at: http://www.abs.gov.au/ausstats/abs%40.nsf/b06660592430724fc a2568b5007b8619/495c8c9d69db4045ca2568a900139402!OpenDocument (accessed Nov 2002).
3. Cunningham J, Paradies Y. Mortality of Aboriginal and Torrest Strait Islander Australians 1997 3315.0. 17-4-2000. Canberra, Australian Bureau of Statistics. Occasional Paper. Available at: http://www.abs.gov.au/ausstats/abs%40.nsf/9cfdfe271b7930bbc a2568b5007b8618/7dfa0774613c8e16ca2568ba001960ca!OpenDocument (accessed Nov 2002).
4. Gardner ID, Wan X, Simms PA, et al. Hepatitis B virus markers in children and staff in Northern Territory schools. Med J Aust 1992; 156: 638-641.
5. Burrell CJ, Cameron AS, Hart G, et al. Hepatitis B reservoirs and attack rates in an Australian community. A basis for vaccination and cross-infection policies. Med J Aust 1983; 2: 492-496.
6. Holman CDJ, Bucens MR, Quadros CF, Reid PM. Occurrence and distribution of hepatitis B infection in the Aboriginal population of Western Australia. Aust N Z J Med 1987; 17: 518-525.
7. Campbell DH, Sargent JW, Plant AJ. The prevalence of markers of infection with hepatitis B virus in a mixed race Australian community. Med J Aust 1989; 150: 489-492.
8. Dempsey KE, Condon JR. Mortality in the Northern Territory 1979-1997, Darwin: Territory Health Services, 1999. Available at: http://www.nt.gov.au/health/health_gains/epidemiology/mortality_NT_1979_1997.pdf (accessed Nov 2002).
9. Wan X, Mathews JD. Primary hepatocellular carcinoma in Aboriginal Australians. Aust J Public Health 1994; 18: 286-290.
10. Scrimgeour D. Screening Issues for Aboriginal People. CARPA Newsletter No. 24. Oct 1996, 4-10.
11. Farrell GC. Chronic viral hepatitis [Practice essentials - Gastroenterology]. Med J Aust 1998; 168: 619-626.
12. Gastroenterological Society of Australia. Hepatitis B. New tests, new treatments, new recommendations. An Information Booklet for Health Care Providers from the Digestive Health Foundation. 2nd Edition. Sydney: Gastroenterological Society of Australia, 2000.
13. Asian Pacific Guidelines on the prevention and management of hepatitis B (core working party for Asia-Pacific Consensus on hepatitis B and C). Consensus statements on the prevention and management of hepatitis B and C in the Asia-Pacific region. J Gastroenterol Hepatol 2000; 15: 825-841.
14. Mahoney FJ. Update on diagnosis, management and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999; 12: 351-366.
15. Badvie S. Hepatocellular carcinoma. Postgrad Med J 2000; 76: 4-11.
16. Beasley PR, Hwang LY, Lin CC. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22707 men in Taiwan. Lancet 1981; 2: 1129-1133.
17. Farrell GC. Towards the eradication of hepatitis B in Australia. Aust N Z J Med 1988; 18: 645.
18. De Jongh FE, Janssen HLA, De Man RA. Survival and prognostic indicators in hepatitis B surface antigen positive cirrhosis of the liver. Gastroenterology 1992; 103: 1630-1635.
19. De Franchis R, Meucci G, Vecchi M, et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993; 118: 191-194.
20. Strasser SI, McCaughan GW. Therapies for chronic hepatitis B: Emerging roles for nucleoside analogues. Aust N Z J Med 2000; 30: 556-558.
21. Niederau C, Heintges T, Lange S, et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334: 1422-1427.
22. Han DJ, Tae HK, Park SK, et al. Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: Comparison with salvage treatment after hepatic dysfunction with HBV recurrence. Transplantation 2001; 71: 367-394.
23. Llovet JM, Bruix J. Early diagnosis and treatment of hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 991-1008.
24. McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaskan natives infected with chronic hepatitis B: A 16-year population based study. Hepatology 2000; 32: 842-846.
25. Lin D, Liaw Y. Optimal surveillance of hepatocellular carcinoma in patients with chronic viral hepatitis. J Gastroenterol Hepatol 2001; 16: 553-559.